Cargando…
Evidence Mapping of the Treatments for Breast Cancer–related Lymphedema: Erratum
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869520/ https://www.ncbi.nlm.nih.gov/pubmed/35223349 http://dx.doi.org/10.1097/GOX.0000000000004224 |
Ejemplares similares
-
Evidence Mapping of the Treatments for Breast Cancer–related Lymphedema
por: Al-Sakkaf, Ali M., et al.
Publicado: (2022) -
Erratum to: Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of Virginia
por: Weiss, Robert
Publicado: (2016) -
Risk Factors for Lymphedema after Thigh Sarcoma Resection and Reconstruction—Erratum
Publicado: (2022) -
Erratum to delivery of vascular endothelial growth factor (VEGFC) via engineered exosomes improves lymphedema
Publicado: (2021) -
Erratum to: Modeling precision treatment of breast cancer
por: Daemen, Anneleen, et al.
Publicado: (2015)